If you need more lookups,
subscriptions start at $34 USD/month.
Michael Soldan Location
Switzerland
Michael Soldan Work
Head of Biosimilars @ (September 2025 - Present)
Senior Consultant and Adviser @ MSBiotechConsulting (April 2024 - September 2025)
Chief Executive Officer @ Polpharma Biologics Group (December 2021 - April 2024)
CEO @ AB2 Bio (April 2020 - December 2021)
EVP Head of Biosimilars @ (September 2017 - April 2020)
SVP Head of Biosimilars @ (October 2015 - September 2017)
VP Medical Affairs, Regulatory Affairs and Drug Safety Biosimilars @ Merck Serono Biosimilars (January 2015 - September 2015)
Head Regulatory Affairs Global Biosimilar Business @ (July 2012 - December 2014)
Senior Vice President Medical and Regulatory Affairs @ (January 2008 - July 2012)
VP Regulatory Affairs @ (July 2006 - December 2007)
VP Corporate Regulatory Affairs @ (January 2005 - June 2006)
Michael Soldan Education
Marburg University
Dr. rer. physiol. (Pharmacy and Human Biology)
Michael Soldan Skills
Vaccines
Clinical Trials
Oncology
Life Sciences
Biopharmaceuticals
Clinical Research
Regulatory Affairs
Drug Safety
Biotechnology
Regulatory Submissions
Monoclonal Antibodies
Pharmaceutical Industry
Protein Chemistry
Medical Affairs
Clinical Development
Pharmacovigilance
Immunology
Safety Management Systems
Regulatory
Business Development
Business Analysis
Healthcare
Leadership
Biosimilars
Hospitals
Strategic Planning
Michael Soldan Summary
Michael Soldan, based in Switzerland, is currently a Head of Biosimilars at Zentiva. Michael Soldan brings experience from previous roles at MSBiotechConsulting, Polpharma Biologics Group, AB2 Bio and Fresenius Kabi. Michael Soldan holds a Dr. rer. physiol. in Pharmacy and Human Biology @ Marburg University. With a robust skill set that includes Vaccines, Clinical Trials, Oncology, Life Sciences, Biopharmaceuticals and more. Michael Soldan has 2 emails on RocketReach.
Looking for a different Michael Soldan?
Find contact details for 700 million professionals.